Dr. Paul Fisher and Dr. Swadesh Das (IMAGE)
Caption
An innovative study – led by Paul B. Fisher, MPh, Ph.D., FNAI, and Swadesh K. Das, Ph.D. – created a Fusion Superkine (FSK) that demonstrated the capability to introduce a combination of treatment outcomes – to potentially achieve a breakthrough in the treatment of glioblastoma brain cancer.
Credit
VCU Massey Comprehensive Cancer Center
Usage Restrictions
with article
License
Original content